ADVERUM BIOTECHNOLOGIES INC (ADVM)
US00773U2078 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 149.61M | 75.00M | 68.40M | 34.20M | 62.40M | |||
| Marketable Securities | 43.72M | 21.53M | 117.20M | 271.00M | 367.30M | |||
| Receivables | N/A | N/A | 0.00 | 5.70M | N/A | |||
| Other Current Assets | 5.80M | 6.25M | 5.00M | 6.20M | 4.70M | |||
| Total Current Assets | 199.13M | 102.77M | 190.60M | 317.10M | 434.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 65.53M | 67.03M | 113.90M | 119.10M | 47.10M | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 3.17M | 3.21M | 3.90M | 2.80M | 1.00M | |||
| Total Non-Current Assets | 68.70M | 70.24M | 117.80M | 122.60M | 48.20M | |||
| TOTAL ASSETS | 267.83M | 173.01M | 308.40M | 439.70M | 482.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 19.54M | 22.89M | 29.80M | 18.60M | 18.10M | |||
| Accounts Payable | 1.90M | 1.92M | 2.20M | 1.40M | 2.80M | |||
| Other Current Liabilities | 109.00K | 101.00K | 300.00K | 1.30M | N/A | |||
| Total Current Liabilities | 21.55M | 24.91M | 32.20M | 21.30M | 20.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 63.99M | 64.63M | 94.60M | 102.20M | 27.30M | |||
| Total Non-Current Liabilities | 63.99M | 64.63M | 94.70M | 102.20M | 27.30M | |||
| TOTAL LIABILITIES | 85.54M | 89.54M | 126.90M | 123.50M | 48.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -944.56M | -919.78M | -802.60M | -648.10M | -502.50M | |||
| Additional Paid In Capital | 1.13B | 1.00B | 985.70M | 965.00M | 937.10M | |||
| Common Shares | 2.00K | 10.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -533.00K | -473.00K | -1.50M | -700.00K | -300.00K | |||
| Shares Outstanding | 20.75M | 10.14M | 100.10M | 98.40M | 97.50M | |||
| Tangible Book Value per Share | 8.78 | 8.23 | 1.81 | 3.21 | 4.45 | |||
| Total Shareholders' Equity | 182.29M | 83.47M | 181.50M | 316.20M | 434.30M | |||
| TOTAL LIABILITIES AND EQUITY | 267.83M | 173.01M | 308.40M | 439.70M | 482.60M | |||
| Statistics | ||||||||
| Current Ratio | 9.24 | 4.13 | 5.92 | 14.89 | 20.78 | |||
| Return On Assets (ROA) | -42.15% | -67.72% | -50.11% | -33.10% | -24.35% | |||
| Return On Equity (ROE) | -61.94% | -140.37% | -85.15% | -46.03% | -27.06% | |||
All data in USD